Liu Joy 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed May 3, 2022
Insider Transaction Report
Form 4
Liu Joy
EVP and Chief Legal Officer
Transactions
- Sale
Common Stock
2022-04-29$274.75/sh−41$11,265→ 14,396 total - Sale
Common Stock
2022-04-29$273.37/sh−17$4,647→ 14,437 total - Sale
Common Stock
2022-04-29$275.62/sh−30$8,269→ 14,366 total - Sale
Common Stock
2022-04-29$278.04/sh−10$2,780→ 14,334 total - Sale
Common Stock
2022-04-29$276.72/sh−22$6,088→ 14,344 total
Footnotes (6)
- [F1]Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1.
- [F2]Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
- [F3]Open market sales reported on this line occurred at a weighted average price of $273.37 (range $273.13 to $273.87).
- [F4]Open market sales reported on this line occurred at a weighted average price of $274.74 (range $274.20 to $275.14).
- [F5]Open market sales reported on this line occurred at a weighted average price of $275.62 (range $275.22 to $276.19).
- [F6]Open market sales reported on this line occurred at a weighted average price of $276.72 (range $276.31 to $277.06).